Pacer Advisors »

Theravance Biopharma shares owned by Pacer Advisors

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Pacer Advisors from 13F filings

Historical chart of Pacer Advisors investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Pacer Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Pacer Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.3M 339k 18.71

More positions owned by Pacer Advisors

NVIDIA Corp Common Stock - Domestic (NVDA)
Newmont Corp Common Stock - Domestic (NEM)
Exxon Mobil Corp Common Stock - Domestic (XOM)
Comcast Corp Common Stock - Domestic (CMCSA)
U.S. Bank Money Market Deposit Account MMDA - Money Market Demand Account
Merck & Co Common Stock - Domestic (MRK)
Bristol-Myers Squibb Common Stock - Domestic (BMY)
Chevron Corp Common Stock - Domestic (CVX)
Altria Group Common Stock - Domestic (MO)
Apple Common Stock - Domestic (AAPL)
At&t Common Stock - Domestic (T)
Verizon Communications Common Stock - Domestic (VZ)
Booking Holdings Common Stock - Domestic (BKNG)
ConocoPhillips Common Stock - Domestic (COP)
Gilead Sciences Common Stock - Domestic (GILD)

View all positions for Pacer Advisors

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
Newtyn Management
BlackRock
Irenic Capital Management
Vanguard Group
Park West Asset Management
D. E. Shaw & Co
Acadian Asset Management
State Street Corporation
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Dimensional Fund Advisors
Oasis Management
UBS Group

View all funds holding Theravance Biopharma